Glaxosmithkline Pharmaceuticals Limited Stock Filter Stocks by Fundamentals
| GLAXO Stock | 2,414 28.15 1.18% |
GlaxoSmithKline Pharmaceuticals Limited fundamentals help investors to digest information that contributes to GlaxoSmithKline Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of GlaxoSmithKline Stock. The fundamental analysis module provides a way to measure GlaxoSmithKline Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GlaxoSmithKline Pharmaceuticals stock.
GlaxoSmithKline | Shares Owned by Insiders |
Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
GlaxoSmithKline Fundamentals
| Return On Equity | 0.42 | ||||
| Return On Asset | 0.17 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.30 % | ||||
| Current Valuation | 382.29 B | ||||
| Shares Outstanding | 169.41 M | ||||
| Shares Owned By Insiders | 75.58 % | ||||
| Shares Owned By Institutions | 8.46 % | ||||
| Price To Book | 24.16 X | ||||
| Price To Sales | 11.48 X | ||||
| Revenue | 34.54 B | ||||
| Gross Profit | 19 B | ||||
| EBITDA | 8.87 B | ||||
| Net Income | 5.9 B | ||||
| Total Debt | 186.65 M | ||||
| Book Value Per Share | 97.18 X | ||||
| Cash Flow From Operations | 5.82 B | ||||
| Earnings Per Share | 39.84 X | ||||
| Target Price | 2914.5 | ||||
| Number Of Employees | 3.21 K | ||||
| Beta | 0.19 | ||||
| Market Capitalization | 408.88 B | ||||
| Total Asset | 35.57 B | ||||
| Retained Earnings | 16.35 B | ||||
| Working Capital | 12.73 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 35.57 B |
About GlaxoSmithKline Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GlaxoSmithKline Pharmaceuticals Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GlaxoSmithKline Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GlaxoSmithKline Pharmaceuticals Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in GlaxoSmithKline Stock
GlaxoSmithKline Pharmaceuticals financial ratios help investors to determine whether GlaxoSmithKline Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GlaxoSmithKline with respect to the benefits of owning GlaxoSmithKline Pharmaceuticals security.